Product category:
Calibration and Laboratory Instruments
News Release from: LGC
Edited by the Manufacturingtalk Editorial
Team on 03 October 2005
Analytical and diagnostic services grow
LGC has published annual results for the year to March 2005 in which it is announced that all areas of the business have grown organically and have contributed to a record annual turnover of £64m.
Europe's leading provider of analytical and diagnostic services and reference standards, has published annual results for the year to March 2005 in which it is announced that all areas of the business have grown organically and have contributed to a record annual turnover of £64m These are the first results following Legal and General Ventures' (LGV) replacement of 3i as LGC's private equity investor in April 2004
This article was originally published on Manufacturingtalk on 10 Mar 2003 at 8.00am (UK)
Related stories
LGC Launches ADME-Tox Screening Service
Bioanalytical services at LGC's new ADME-Tox laboratory include in vitro drug metabolism, cellular toxicology and prediction of gastrointestinal transport.
Phytochemical Reference Standards Now Available
Over 2500 high purity ChromaDex phytochemical - or herbal - reference standards are now available exclusively from LGC Promochem throughout Europe.
Brian Phillips of LGV, and a non-executive director of LGC, said: "LGC is proving its potential to grow, both organically and by acquisition.
The current markets for analytical and diagnostic services in which LGC operates are providing favourable opportunities for the Group to increase its capacity and the scope of its services in the UK, Europe and in India.
I am delighted by LGC's results in the first year and am pleased to be able to support the company's 'buy and build' strategy." Dr Nigel Law, LGC's Chief Executive, said: "LGC is expanding rapidly.
We have recently acquired Forensic Alliance Limited, the UK's largest private sector provider of forensic science services to investigators and the courts.
Internationally, we are in the process of constructing a new laboratory in India so that we can build on the chemical synthesis capability currently provided to the generic pharmaceutical industry through our operations in Luckenwalde, Germany.
"Alongside these more commercial developments, I am keen to strengthen LGC's role as the National Measurement Institute for chemical and biochemical analysis.
This was enhanced during the year by our involvement in the new DTI programme - Measurement for Emerging Technologies - under the medical technologies theme.
We also received DTI approval for a new three-year programme supporting the Government Chemist function.".
• LGC: contact details and other news
• Email this article to a colleague
• Register for the free Manufacturingtalk email newsletter
• Manufacturingtalk Home Page
Search the Pro-Talk network of sites
